from Reuters: Health News https://reut.rs/2Hao93E
Sunday, May 12, 2019
Sunday, May 12, 2019
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Novartis AG is offering price discounts in negotiations with U.S. health insurers on its gene therapy for spinal muscular atrophy (SMA), a treatment that could cost more than a million dollars, but the gesture comes with strings attached.

from Reuters: Health News https://reut.rs/2Hao93E
from Reuters: Health News https://reut.rs/2Hao93E
Related Posts:
LATEST HEALTH NEWSIn at least 15 countries C-section use exceeds 40 per cent, researchers said from Health https://ift.tt/2OUjfwA … Read More
LATEST HEALTH NEWSA New Jersey jury on Thursday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer. … Read More
LATEST HEALTH NEWSThe new research undercuts widely held beliefs about strenuous physical training and pregnancy from Health https://ift.tt/2pQAdhh … Read More
LATEST HEALTH NEWSThe relationship between the public and private healthcare systems in India is tenuous from Health https://ift.tt/2INyK3U … Read More
LATEST HEALTH NEWSAbbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat version of blockbuster drug, Humira. from Reuters: Health News https://if… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment